Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 2
1999 1
2000 1
2002 1
2003 2
2005 3
2006 3
2007 2
2008 1
2009 1
2010 2
2011 1
2012 1
2013 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Mechanism of decongestant activity of alpha 2-adrenoceptor agonists.
Corboz MR, Rivelli MA, Mingo GG, McLeod RL, Varty L, Jia Y, Hey JA. Corboz MR, et al. Among authors: rivelli ma. Pulm Pharmacol Ther. 2008;21(3):449-54. doi: 10.1016/j.pupt.2007.06.007. Epub 2007 Jul 17. Pulm Pharmacol Ther. 2008. PMID: 17869148
alpha2-adrenoceptor agonists as nasal decongestants.
Corboz MR, Mutter JC, Rivelli MA, Mingo GG, McLeod RL, Varty L, Jia Y, Cartwright M, Hey JA. Corboz MR, et al. Among authors: rivelli ma. Pulm Pharmacol Ther. 2007;20(2):149-56. doi: 10.1016/j.pupt.2006.03.012. Epub 2006 May 6. Pulm Pharmacol Ther. 2007. PMID: 16809058
Pharmacological characterization of a novel α2C-adrenoceptor agonist N-[3,4-dihydro-4-(1H-imidazol-4-ylmethyl)-2H-1, 4-benzoxazin-6-yl]-N-ethyl-N'-methylurea (compound A).
Corboz MR, Rivelli MA, McCormick KD, Wan Y, Shah H, Umland S, Lieber G, Jia Y, McLeod RL, Morgan C, Varty GB, Wu J, Feng KI, Boyce CW, Aslanian RG, Palamanda J, Nomeir AA, Korfmacher W, Hunter JC, Anthes JC, Hey JA. Corboz MR, et al. Among authors: rivelli ma. J Pharmacol Exp Ther. 2011 Apr;337(1):256-66. doi: 10.1124/jpet.110.175794. Epub 2011 Jan 13. J Pharmacol Exp Ther. 2011. PMID: 21233198
Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M, Ting PC, Vaccaro WD, Aslanian R, McCormick KD, Lee JF, Albanese MM, Mutahi MW, Piwinski JJ, Shih NY, Duguma L, Solomon DM, Zhou W, Sher R, Favreau L, Bryant M, Korfmacher WA, Nardo C, West RE Jr, Anthes JC, Williams SM, Wu RL, Susan She H, Rivelli MA, Corboz MR, Hey JA. Berlin M, et al. Among authors: rivelli ma. Bioorg Med Chem Lett. 2006 Feb 15;16(4):989-94. doi: 10.1016/j.bmcl.2005.10.087. Epub 2005 Nov 15. Bioorg Med Chem Lett. 2006. PMID: 16297617
Novel H3 receptor antagonists. Sulfonamide homologs of histamine.
Wolin R, Connolly M, Afonso A, Hey JA, She H, Rivelli MA, Willams SM, West RE Jr. Wolin R, et al. Among authors: rivelli ma. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2157-62. doi: 10.1016/s0960-894x(98)00379-5. Bioorg Med Chem Lett. 1998. PMID: 9873505
The synthesis and structure-activity relationship of 4-benzimidazolyl-piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists.
Ting PC, Lee JF, Albanese MM, Wu J, Aslanian R, Favreau L, Nardo C, Korfmacher WA, West RE, Williams SM, Anthes JC, Rivelli MA, Corboz MR, Hey JA. Ting PC, et al. Among authors: rivelli ma. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5004-8. doi: 10.1016/j.bmcl.2010.07.052. Epub 2010 Jul 16. Bioorg Med Chem Lett. 2010. PMID: 20685118
18 results